Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene

被引:343
作者
Li, M
Pascual, G
Glass, CK
机构
[1] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA
关键词
D O I
10.1128/MCB.20.13.4699-4707.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peroxisome proliferator-activated receptor gamma (PPAR gamma) is a member of the nuclear receptor superfamily that activates target gene transcription in a ligand-dependent manner. In addition, liganded PPAR gamma can inhibit transcription of genes induced by gamma interferon (IFN-gamma) and/or lipopolysaccharides (LPSs), including the inducible nitric oxide synthase (iNOS) gene. Inhibition of the iNOS promoter is achieved partially through antagonizing the activities of NF-kappa B, AP-1, and STAT1, which are known to mediate effects of LPS and IFN-gamma. Previous studies have suggested that transrepression of these factors by nuclear receptors involves competition for limiting amounts of the general coactivators CREB-binding protein (CBP) and p300. CBP and p300 are thought to be recruited to nuclear receptors through bridging factors that include SRC-1, although CBP also interacts directly with PPAR gamma through its amino terminus. These observations have raised questions concerning the involvement of SRC-1-like factors in CBP recruitment and transrepression. We here provide evidence that PPAR gamma's ability to repress iNOS transcription requires the ligand-dependent charge clamp that mediates interactions with CBP and SRC-1. Single amino acid mutations in PPAR gamma that abolished ligand-dependent interactions with SRC-1 and CBP not only resulted in complete loss of transactivation activity but also abolished transrepression. Conversely, a CBP deletion mutant containing the SRC-1 interaction domain but lacking the N-terminal PPAR gamma interaction domain was inactive as a PPAR gamma coactivator and failed to rescue transrepression. Together, these findings are consistent with a model in which transrepression by PPAR gamma is achieved by targeting CBP through direct interaction with its N-terminal domain and via SRC-1-like bridge factors.
引用
收藏
页码:4699 / 4707
页数:9
相关论文
共 59 条
  • [51] The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
    Torchia, J
    Rose, DW
    Inostroza, J
    Kamei, Y
    Westin, S
    Glass, CK
    Rosenfeld, MG
    [J]. NATURE, 1997, 387 (6634) : 677 - 684
  • [52] The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
    Voegel, JJ
    Heine, MJS
    Tini, M
    Vivat, V
    Chambon, P
    Gronemeyer, H
    [J]. EMBO JOURNAL, 1998, 17 (02) : 507 - 519
  • [53] TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
    Voegel, JJ
    Heine, MJS
    Zechel, C
    Chambon, P
    Gronemeyer, H
    [J]. EMBO JOURNAL, 1996, 15 (14) : 3667 - 3675
  • [54] Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
    Westin, S
    Kurokawa, R
    Nolte, RT
    Wisely, GB
    McInerney, EM
    Rose, DW
    Milburn, MV
    Rosenfeld, MG
    Glass, CK
    [J]. NATURE, 1998, 395 (6698) : 199 - 202
  • [55] The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
    Willson, TM
    Cobb, JE
    Cowan, DJ
    Wiethe, RW
    Correa, ID
    Prakash, SR
    Beck, KD
    Moore, LB
    Kliewer, SA
    Lehmann, JM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) : 665 - 668
  • [56] TRANSCRIPTIONAL INTERFERENCE BETWEEN C-JUN AND THE GLUCOCORTICOID RECEPTOR - MUTUAL INHIBITION OF DNA-BINDING DUE TO DIRECT PROTEIN PROTEIN-INTERACTION
    YANGYEN, HF
    CHAMBARD, JC
    SUN, YL
    SMEAL, T
    SCHMIDT, TJ
    DROUIN, J
    KARIN, M
    [J]. CELL, 1990, 62 (06) : 1205 - 1215
  • [57] Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
    Yao, TP
    Oh, SP
    Fuchs, M
    Zhou, ND
    Ch'ng, LE
    Newsome, D
    Bronson, RT
    Li, E
    Livingston, DM
    Eckner, R
    [J]. CELL, 1998, 93 (03) : 361 - 372
  • [58] Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma
    Zhang, B
    Berger, J
    Zhou, GC
    Elbrecht, A
    Biswas, S
    WhiteCarrington, S
    Szalkowski, D
    Moller, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) : 31771 - 31774
  • [59] Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
    Zhou, GC
    Cummings, R
    Li, Y
    Mitra, S
    Wilkinson, HA
    Elbrecht, A
    Hermes, JD
    Schaeffer, JM
    Smith, RG
    Moller, DE
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (10) : 1594 - 1604